Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 2
2014 3
2015 3
2016 7
2017 13
2018 15
2019 8
2020 18
2021 16
2022 7
2023 7
2024 4
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

89 results

Results by year

Filters applied: . Clear all
Page 1
The effectiveness of second- and-third-line biologics in perianal Crohn's disease-a multicenter propensity score-matched study.
Shani U, State M, Mateescu RB, Davidoiu AM, Negreanu L, Silva I, Magro F, Lees CW, Plevris N, Roblin X, Castellet-Farrús S, Gonzalez Lama Y, Wang S, Abad C, Imperatore N, Lukas M, Vojtechova G, Ukashi O, Ben-Horin S, Nancey S, Savarino E, Stawczyk-Eder K, Eder P, Toskas A, Kamperidis N, Arebi N, Farkas B, Farkas K, Pipek B, Falt P, Karmiris K, Nikolaou P, Krznaric Z, Brinar M, Hoentjen F, van Lierop L, Barreiro-de Acosta M, Zaborowska M, Zagorowicz E, Pugliese D, Cuccia G, Truyens M, Kopylov U. Shani U, et al. Among authors: imperatore n. J Crohns Colitis. 2025 Jun 4;19(6):jjaf099. doi: 10.1093/ecco-jcc/jjaf099. J Crohns Colitis. 2025. PMID: 40490896
Therapy in elderly IBD patients.
Castiglione F, Imperatore N, Zingone F, D'Incà R. Castiglione F, et al. Among authors: imperatore n. Minerva Gastroenterol (Torino). 2024 Mar;70(1):89-97. doi: 10.23736/S2724-5985.21.02895-3. Epub 2021 Jun 23. Minerva Gastroenterol (Torino). 2024. PMID: 34160188
Real-life effectiveness and safety of tofacitinib and vedolizumab as 2nd-line for ulcerative colitis after anti-TNFs: A multicenter cohort IGIBD study (VE2TO-UC).
Noviello D, Fries W, Orlando A, Conforti FS, Bezzio C, Castiglione F, Fantini MC, Savarino EV, Festa S, Ribaldone DG, Mocci G, Grossi L, Viganò C, Imperatore N, Ceccarelli L, Gabrielli AMC, Scardino G, Saibeni S, Balestrieri P, Principi M, Campigotto M, Gravina AG, Spagnuolo R, Scaldaferri F, Neri B, Sario AD, Baldoni M, Mitri RD, Tettoni E, Calderone S, Armuzzi A, Macaluso FS, Vecchi M, Ventimiglia M, Caprioli F; VE2TO-UC study group. Noviello D, et al. Among authors: imperatore n. Dig Liver Dis. 2025 Jul;57(7):1419-1427. doi: 10.1016/j.dld.2025.04.025. Epub 2025 May 6. Dig Liver Dis. 2025. PMID: 40335332
Fecal calprotectin in coeliac disease.
Capone P, Rispo A, Imperatore N, Caporaso N, Tortora R. Capone P, et al. Among authors: imperatore n. World J Gastroenterol. 2014 Jan 14;20(2):611-2. doi: 10.3748/wjg.v20.i2.611. World J Gastroenterol. 2014. PMID: 24574734 Free PMC article.
89 results